Skip to main content
Equibles
CBIO logo

CBIO · Crescent Biopharma, Inc.

Track CBIO — free

Use CBIO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CBIO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$17.00 +0.03 (+0.18%) At close · Aug 25
Market Cap
$631.45M
Shares
37.14M

Crescent Biopharma, Inc. Earnings Call Transcripts

Quarterly earnings calls for Crescent Biopharma, Inc. (CBIO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼88.3% $1.06M −$14.27M '21 Q1 21-05-03 · $142 −$14.40M '21 Q2 21-08-05 ▼91.3% $86,560 −$17.33M '21 Q3 21-11-02 · $17,624 −$17.42M '21 Q4 22-03-03 ▲52716.9% $75,000 −$13.27M '22 Q2 22-08-03 · $ −$15.15M '25 Q1 25-06-18 LATEST · $1.04M −$23.28M '26 Q1 26-05-26
Conference
Investor event
2026-06-08
Crescent Biopharma, Inc. (CBIO) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Crescent Biopharma, Inc. (CBIO) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-26
Crescent Biopharma, Inc. (CBIO) Q1 2026 Earnings Call
Revenue
$1.04M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-06-18
Crescent Biopharma, Inc. (CBIO) Q1 2025 Earnings Call
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Crescent Biopharma, Inc. (CBIO) Q1 2024 Earnings Call
Diluted EPS
$-4.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
Crescent Biopharma, Inc. (CBIO) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Crescent Biopharma, Inc. (CBIO) Q3 2023 Earnings Call
Diluted EPS
$-14.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Crescent Biopharma, Inc. (CBIO) Q2 2023 Earnings Call
Diluted EPS
$-13.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Crescent Biopharma, Inc. (CBIO) Q1 2023 Earnings Call
Diluted EPS
$-17.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Crescent Biopharma, Inc. (CBIO) Q4 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Crescent Biopharma, Inc. (CBIO) Q3 2022 Earnings Call
Diluted EPS
$-16.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Crescent Biopharma, Inc. (CBIO) Q2 2022 Earnings Call
Revenue
$75,000
▲ 52716.9% YoY
Diluted EPS
$-25.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Crescent Biopharma, Inc. (CBIO) Q1 2022 Earnings Call
Diluted EPS
$-28.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Crescent Biopharma, Inc. (CBIO) Q4 2021 Earnings Call
Revenue
$17,624*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Crescent Biopharma, Inc. (CBIO) Q3 2021 Earnings Call
Revenue
$86,560
▼ 91.3% YoY
Diluted EPS
$-34.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Crescent Biopharma, Inc. (CBIO) Q2 2021 Earnings Call
Revenue
$142
Diluted EPS
$-28.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-03
Crescent Biopharma, Inc. (CBIO) Q1 2021 Earnings Call
Revenue
$1.06M
▼ 88.3% YoY
Diluted EPS
$-28.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-02
Crescent Biopharma, Inc. (CBIO) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-06
Crescent Biopharma, Inc. (CBIO) Q3 2020 Earnings Call
Revenue
$1.00M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-31
Crescent Biopharma, Inc. (CBIO) Q2 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-01
Crescent Biopharma, Inc. (CBIO) Q1 2020 Earnings Call
Revenue
$9.00M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-28
Crescent Biopharma, Inc. (CBIO) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–22 of 22 earnings calls
Key facts CIK 1253689 CUSIP G2545C104 13F (30d) 75 filings 75 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)